Search clinical trials for: HER-2 Positive Breast Cancer
Total 133562 results
-
Thomas HatschekActive, not recruitingEarly-Stage Breast Carcinoma | HER-2 Positive Breast CancerSweden
-
Bavarian NordicCompletedBreast CancerUnited States
-
University Hospital, BrestUnknownBreast Neoplasms | HER-2 Gene AmplificationFrance
-
Jules Bordet InstituteRoche Pharma AGActive, not recruitingHER-2 Positive Breast CancerBelgium, Netherlands
-
University of Michigan Rogel Cancer CenterGenentech, Inc.CompletedHER-2 Positive Metastatic Breast CancerUnited States
-
Asociación para el Progreso de la Oncología en...Roche Farma, S.ACompleted
-
Osaka Medical CollegeCompletedBreast Cancer | Effects of Chemotherapy | HER-2 Positive Breast CancerJapan
-
Fudan UniversityRecruitingHormone Receptor Positive HER-2 Negative Breast CancerChina
-
University Hospital TuebingenUniversity Hospital Freiburg; University Hospital UlmRecruitingHormone Receptor Positive HER-2 Negative Breast CancerGermany
-
BiocadCompletedHuman Epithelial Receptor (HER)-2 Positive Breast CancerUkraine, Russian Federation, Belarus, India
-
University of WashingtonNational Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
GlaxoSmithKlineTerminatedNeoplasms, BreastItaly, United Kingdom
-
Xiangya Hospital of Central South UniversityNot yet recruiting
-
Fudan UniversityGeneQuantum Healthcare (Suzhou) Co., Ltd.RecruitingAdvanced/ Metastatic Her-2 Positive Breast CancerChina
-
Novartis PharmaceuticalsCompletedMetastatic Breast Cancer | HER-2 Positive Breast CancerBelgium, Netherlands, Australia, Italy, United States
-
Alliance Foundation Trials, LLC.Pfizer; Syneos Health; UNICANCER; German Breast Group; SOLTI Breast Cancer Research... and other collaboratorsActive, not recruitingHER-2 Positive Breast Cancer | Estrogen Receptor Positive Breast CancerUnited States, Spain, France, Italy, Germany, Australia, Portugal, New Zealand
-
Novartis PharmaceuticalsCompletedMetastatic Breast CancerBelgium, France, Netherlands, United States, Spain
-
Fujian Medical University Union HospitalNot yet recruiting
-
Centre Hospitalier Universitaire VaudoisNot yet recruitingStroke | Executive DysfunctionSwitzerland
-
Henan Cancer HospitalQilu Pharmaceutical Co., Ltd.; Beijing Biostar Pharmaceuticals Co., Ltd.Not yet recruitingHER-2 Negative Breast Cancer
-
Eli Lilly and CompanyCompletedHER-2 Positive Breast Cancer | Hormone Receptor Positive Breast CancerSpain, United States, Korea, Republic of, Belgium, France, Germany, Italy, Australia, Argentina, Canada, United Kingdom, Mexico, Brazil, Greece
-
University of Maryland, BaltimoreWithdrawnBreast Cancer With Brain MetastasisUnited States
-
Georgetown UniversityUniversity of Chicago; Thomas Jefferson UniversityCompletedHormone Receptor Positive HER-2 Negative Breast CancerUnited States
-
Istituto Scientifico Romagnolo per lo Studio e...TerminatedHER-2 Positive Breast Cancer | Malignant Neoplasm of BreastItaly
-
Hanmi Pharmaceutical Company LimitedNational OncoVentureCompletedHER-2 Positive Advanced Gastric CancerKorea, Republic of
-
Texas Tech University Health Sciences Center, El...WithdrawnBreast Cancer | Metastatic Breast Cancer | HER-2 Positive Breast Cancer | ER Positive Breast Cancer
-
National Cancer Centre, SingaporeCompletedHER 2 Positive Advanced Gastric CancerSingapore
-
Duke UniversityNational Cancer Institute (NCI)CompletedBreast Cancer | Gastric Cancer | Ovarian CancerUnited States
-
Lucia Del Mastro,MDCompleted
-
Kadmon Corporation, LLCTerminatedHER-2 Positive Breast Cancer | Metastatic Malignant Neoplasm to BrainUnited States
-
Osaka Medical CollegeTerminatedBreast Cancer | HER-2 Positive Breast Cancer | Estrogen Receptor Negative NeoplasmJapan
-
Cancer Institute and Hospital, Chinese Academy...RecruitingCarcinoma, Transitional Cell | HER-2 Gene AmplificationChina
-
Fudan UniversityUnknownHER-2 Negative Breast CancerChina
-
H. Lee Moffitt Cancer Center and Research InstituteUnited States Department of DefenseActive, not recruitingBreast Cancer, Male | HER2-positive Breast Cancer | Breast Cancer Stage I | Breast Cancer Stage II | Breast Cancer Female | Breast Cancer Stage III | Residual Disease | HER2 Positive Breast CarcinomaUnited States
-
Dana-Farber Cancer InstituteGenentech, Inc.Active, not recruitingBreast Cancer | Stage II Breast Cancer | HER-2 Positive Breast Cancer | Stage III Breast CancerUnited States
-
Aston Sci. Inc.TerminatedBreast CancerUnited States, Taiwan
-
Adrienne G. WaksEli Lilly and Company; Verastem, Inc.RecruitingBreast Cancer | Hormone Receptor-positive Breast Cancer | Hormone Receptor Positive HER-2 Negative Breast CancerUnited States
-
Anhui Provincial HospitalUnknownHER2 Positive Breast Carcinoma
-
Genentech, Inc.Completed
-
Ying LinRecruitingHer-2 Negative Breast Cancer | HRR Gene MutationChina
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Genentech... and other collaboratorsCompletedBreast Cancer | Carcinoma of the BreastUnited States
-
Dana-Farber Cancer InstituteGenentech, Inc.; Eisai Inc.TerminatedMetastatic Breast Cancer | HER2-positive Breast CancerUnited States
-
Morten Mau-SørensenOdense University Hospital; Aarhus University Hospital; Aalborg University HospitalRecruitingEsophageal Squamous Cell Carcinoma | HER-2 Gene Amplification | HER-2 Protein OverexpressionDenmark
-
Meiji Seika Pharma Co., Ltd.Dong-A PharmaceuticalCompleted
-
Hamilton Health Sciences CorporationMcMaster University; Canadian Breast Cancer Research Alliance; Ontario Cancer...CompletedBreast NeoplasmsCanada
-
iOMEDICO AGNovartis PharmaceuticalsCompletedBreast Cancer | Hormone Receptor Positive Tumor | HER 2 Negative Breast CancerGermany
-
Li HuipingNot yet recruiting
-
Jules Bordet InstituteCompletedCarcinoma Breast Stage IVBelgium
-
Peking UniversityJiangsu HengRui Medicine Co., Ltd.Unknown
-
University of Kansas Medical CenterTerminatedMetastatic Breast CancerUnited States